A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00838110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind Placebo-Controlled Study To Evaluate The Safety And Tolerability Of Dimebon (PF-01913539) For Up To 26-Weeks In Patients With Mild To Moderate Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, randomized, double-blind placebo-controlled safety study conducted in 2 study cohorts. In Cohort 1, subjects with Alzheimer's disease (n=250) will receive Dimebon 20 mg or placebo TID for 26 weeks. In Cohort 2 AD subjects (n=500) will be treated with Dimebon 20 mg or placebo TID for 12 weeks After completion of the randomized portion of the study, subjects in both Cohorts will have the opportunity to enroll in a Dimebon open label extension study.
Study identification
- NCT ID
- NCT00838110
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 742 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2009 (Type not available)
- Primary completion
- Jan 2010 (Actual)
- Completion
- Jan 2010 (Actual)
- Last update posted
- Dec 6, 2018
2009 – 2010
United States locations
- U.S. sites
- 93
- U.S. states
- 32
- U.S. cities
- 85
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mobile | Alabama | 36608 | — |
| Pfizer Investigational Site | Northport | Alabama | 35476 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | Oceanside | California | 92056 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | Santa Rosa | California | 95405 | — |
| Pfizer Investigational Site | Pueblo | Colorado | 81001 | — |
| Pfizer Investigational Site | Hockessin | Delaware | 19707 | — |
| Pfizer Investigational Site | Bradenton | Florida | 34205 | — |
| Pfizer Investigational Site | Brooksville | Florida | 34601 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33756 | — |
| Pfizer Investigational Site | Daytona Beach | Florida | 32114 | — |
| Pfizer Investigational Site | Daytona Beach | Florida | 32117 | — |
| Pfizer Investigational Site | Destin | Florida | 32541 | — |
| Pfizer Investigational Site | Fort Myers | Florida | 33912 | — |
| Pfizer Investigational Site | Fort Walton Beach | Florida | 32547 | — |
| Pfizer Investigational Site | Fruitland Park | Florida | 34731 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32901 | — |
| Pfizer Investigational Site | Naples | Florida | 34102 | — |
| Pfizer Investigational Site | Ocala | Florida | 34471 | — |
| Pfizer Investigational Site | Ocala | Florida | 34474 | — |
| Pfizer Investigational Site | Orlando | Florida | 32806 | — |
| Pfizer Investigational Site | Plant City | Florida | 33563 | — |
| Pfizer Investigational Site | Port Charlotte | Florida | 33952 | — |
| Pfizer Investigational Site | Port Orange | Florida | 32127 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33709 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33713 | — |
| Pfizer Investigational Site | Tampa | Florida | 33606 | — |
| Pfizer Investigational Site | Tampa | Florida | 33629 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30308 | — |
| Pfizer Investigational Site | Burr Ridge | Illinois | 60527 | — |
| Pfizer Investigational Site | Elk Grove Village | Illinois | 60007 | — |
| Pfizer Investigational Site | Elkhart | Indiana | 46514 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47714 | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | 46805 | — |
| Pfizer Investigational Site | Greenfield | Indiana | 46140-2834 | — |
| Pfizer Investigational Site | Prairie Village | Kansas | 66206 | — |
| Pfizer Investigational Site | Wichita | Kansas | 67207 | — |
| Pfizer Investigational Site | Lake Charles | Louisiana | 70601 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105 | — |
| Pfizer Investigational Site | West Yarmouth | Massachusetts | 02763 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | Olive Branch | Mississippi | 38654 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64114 | — |
| Pfizer Investigational Site | Springfield | Missouri | 65807 | — |
| Pfizer Investigational Site | Great Falls | Montana | 59405 | — |
| Pfizer Investigational Site | Eatontown | New Jersey | 07724 | — |
| Pfizer Investigational Site | Oakhurst | New Jersey | 07755 | — |
| Pfizer Investigational Site | Toms River | New Jersey | 08755 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Pfizer Investigational Site | Amherst | New York | 14226 | — |
| Pfizer Investigational Site | Buffalo | New York | 14211 | — |
| Pfizer Investigational Site | Buffalo | New York | 14215 | — |
| Pfizer Investigational Site | Orchard Park | New York | 14127 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28211 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27607 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27612 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58103 | — |
| Pfizer Investigational Site | Fargo | North Dakota | 58104 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45227 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Altoona | Pennsylvania | 16602 | — |
| Pfizer Investigational Site | Beaver | Pennsylvania | 15009 | — |
| Pfizer Investigational Site | Bridgeville | Pennsylvania | 15017 | — |
| Pfizer Investigational Site | Grove City | Pennsylvania | 16127 | — |
| Pfizer Investigational Site | Indiana | Pennsylvania | 15701 | — |
| Pfizer Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15241 | — |
| Pfizer Investigational Site | Scotland | Pennsylvania | 17254 | — |
| Pfizer Investigational Site | Upper Saint Clair | Pennsylvania | 15241 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Greer | South Carolina | 29651 | — |
| Pfizer Investigational Site | Murrells Inlet | South Carolina | 29576 | — |
| Pfizer Investigational Site | North Charleston | South Carolina | 29406-6076 | — |
| Pfizer Investigational Site | Orangeburg | South Carolina | 29118 | — |
| Pfizer Investigational Site | Sioux Falls | South Dakota | 57105 | — |
| Pfizer Investigational Site | Franklin | Tennessee | 37067 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | Carrollton | Texas | 75007 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76104 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76117 | — |
| Pfizer Investigational Site | Grand Prairie | Texas | 75050 | — |
| Pfizer Investigational Site | Houston | Texas | 77074 | — |
| Pfizer Investigational Site | Lake Jackson | Texas | 77566 | — |
| Pfizer Investigational Site | Williamsburg | Virginia | 23185 | — |
| Pfizer Investigational Site | Kirkland | Washington | 98033 | — |
| Pfizer Investigational Site | Spokane | Washington | 99216 | — |
| Pfizer Investigational Site | Charleston | West Virginia | 25304 | — |
| Pfizer Investigational Site | La Crosse | Wisconsin | 54650 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00838110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00838110 live on ClinicalTrials.gov.